Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literatureSébastien Sanges, David Launay, N. Le Gouellec et al.|Autoimmunity Reviews|2017Cited by 63
Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational studyAnne Murarasu, C. Bélizna, G. Guettrot-Imbert et al.|The Lancet Rheumatology|2022Cited by 24
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)F. Barde, Benjamin Chaigne, Kévin Chevalier et al.|Journal of Autoimmunity|2025Cited by 4
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: ReplyGelsomina Alle, C. Durant, G. Guettrot-Imbert et al.|Lara D. Veeken|2024Cited by 1
Utilisation des immunoglobulines intraveineuses au cours de la sclérodermie systémique : étude rétrospective multicentriqueSébastien Sanges, David Launay, Sébastien Rivière et al.|La Revue de Médecine Interne|2017Cited by 0